Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Harvard

Freedman, B, Hindricks, G, Banerjee, A, Baranchuk, A, Ching, CK, Du, X, Fitzsimons, D, Healey, JS, Ikeda, T, Lobban, TCA, Mbakwem, A, Narasimhan, C, Neubeck, L, Noseworthy, P, Philbin, DM, Pinto, FJ, Rwebembera, J, Schnabel, RB, Svendsen, JH, Aguinaga, L, Arbelo, E, Böhm, M, Farhan, HA, Hobbs, FDR, Martínez-Rubio, A, Militello, C, Naik, N, Noubiap, JJ, Perel, P, Piñeiro, DJ, Ribeiro, AL & Stepinska, J 2021, 'World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update', Global Heart, bind 16, nr. 1, 41, s. 41. https://doi.org/10.5334/GH.1023

APA

Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T. C. A., Mbakwem, A., Narasimhan, C., Neubeck, L., Noseworthy, P., Philbin, D. M., Pinto, F. J., Rwebembera, J., Schnabel, R. B., Svendsen, J. H., ... Stepinska, J. (2021). World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Global Heart, 16(1), 41. [41]. https://doi.org/10.5334/GH.1023

CBE

Freedman B, Hindricks G, Banerjee A, Baranchuk A, Ching CK, Du X, Fitzsimons D, Healey JS, Ikeda T, Lobban TCA, Mbakwem A, Narasimhan C, Neubeck L, Noseworthy P, Philbin DM, Pinto FJ, Rwebembera J, Schnabel RB, Svendsen JH, Aguinaga L, Arbelo E, Böhm M, Farhan HA, Hobbs FDR, Martínez-Rubio A, Militello C, Naik N, Noubiap JJ, Perel P, Piñeiro DJ, Ribeiro AL, Stepinska J. 2021. World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Global Heart. 16(1):41. https://doi.org/10.5334/GH.1023

MLA

Vancouver

Freedman B, Hindricks G, Banerjee A, Baranchuk A, Ching CK, Du X o.a. World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Global Heart. 2021 maj 27;16(1):41. 41. https://doi.org/10.5334/GH.1023

Author

Freedman, Ben ; Hindricks, Gerhard ; Banerjee, Amitava ; Baranchuk, Adrian ; Ching, Chi Keong ; Du, Xin ; Fitzsimons, Donna ; Healey, Jeff S ; Ikeda, Takanori ; Lobban, Trudie C A ; Mbakwem, Amam ; Narasimhan, Calambur ; Neubeck, Lis ; Noseworthy, Peter ; Philbin, Daniel M ; Pinto, Fausto J ; Rwebembera, Joselyn ; Schnabel, Renate B ; Svendsen, Jesper Hastrup ; Aguinaga, Luis ; Arbelo, Elena ; Böhm, Michael ; Farhan, Hasan Ali ; Hobbs, F D Richard ; Martínez-Rubio, Antoni ; Militello, Claudio ; Naik, Nitish ; Noubiap, Jean Jacques ; Perel, Pablo ; Piñeiro, Daniel José ; Ribeiro, Antonio Luiz ; Stepinska, Janina. / World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. I: Global Heart. 2021 ; Bind 16, Nr. 1. s. 41.

Bibtex

@article{3f504b2bd2f84ed8916146c6140072b5,
title = "World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update",
abstract = "The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death and disability. Atrial fibrillation (AF) is one of these conditions and is an increasing problem due to ageing of the world's population and an increase in cardiovascular risk factors that predispose to AF. The goal of the AF roadmap was to provide guidance on priority interventions that are feasible in multiple countries, and to identify roadblocks and potential strategies to overcome them. Since publication of the AF Roadmap in 2017, there have been many technological advances including devices and artificial intelligence for identification and prediction of unknown AF, better methods to achieve rhythm control, and widespread uptake of smartphones and apps that could facilitate new approaches to healthcare delivery and increasing community AF awareness. In addition, the World Health Organisation added the non-vitamin K antagonist oral anticoagulants (NOACs) to the Essential Medicines List, making it possible to increase advocacy for their widespread adoption as therapy to prevent stroke. These advances motivated the WHF to commission a 2020 AF Roadmap update. Three years after the original Roadmap publication, the identified barriers and solutions were judged still relevant, and progress has been slow. This 2020 Roadmap update reviews the significant changes since 2017 and identifies priority areas for achieving the goals of reducing death and disability related to AF, particularly targeted at low-middle income countries. These include advocacy to increase appreciation of the scope of the problem; plugging gaps in guideline management and prevention through physician education, increasing patient health literacy, and novel ways to increase access to integrated healthcare including mHealth and digital transformations; and greater emphasis on achieving practical solutions to national and regional entrenched barriers. Despite the advances reviewed in this update, the task will not be easy, but the health rewards of implementing solutions that are both innovative and practical will be great.",
author = "Ben Freedman and Gerhard Hindricks and Amitava Banerjee and Adrian Baranchuk and Ching, {Chi Keong} and Xin Du and Donna Fitzsimons and Healey, {Jeff S} and Takanori Ikeda and Lobban, {Trudie C A} and Amam Mbakwem and Calambur Narasimhan and Lis Neubeck and Peter Noseworthy and Philbin, {Daniel M} and Pinto, {Fausto J} and Joselyn Rwebembera and Schnabel, {Renate B} and Svendsen, {Jesper Hastrup} and Luis Aguinaga and Elena Arbelo and Michael B{\"o}hm and Farhan, {Hasan Ali} and Hobbs, {F D Richard} and Antoni Mart{\'i}nez-Rubio and Claudio Militello and Nitish Naik and Noubiap, {Jean Jacques} and Pablo Perel and Pi{\~n}eiro, {Daniel Jos{\'e}} and Ribeiro, {Antonio Luiz} and Janina Stepinska",
note = "Copyright: {\textcopyright} 2021 The Author(s).",
year = "2021",
month = may,
day = "27",
doi = "10.5334/GH.1023",
language = "English",
volume = "16",
pages = "41",
journal = "Global Heart",
issn = "2211-8160",
publisher = "Elsevier Science & Technology",
number = "1",

}

RIS

TY - JOUR

T1 - World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update

AU - Freedman, Ben

AU - Hindricks, Gerhard

AU - Banerjee, Amitava

AU - Baranchuk, Adrian

AU - Ching, Chi Keong

AU - Du, Xin

AU - Fitzsimons, Donna

AU - Healey, Jeff S

AU - Ikeda, Takanori

AU - Lobban, Trudie C A

AU - Mbakwem, Amam

AU - Narasimhan, Calambur

AU - Neubeck, Lis

AU - Noseworthy, Peter

AU - Philbin, Daniel M

AU - Pinto, Fausto J

AU - Rwebembera, Joselyn

AU - Schnabel, Renate B

AU - Svendsen, Jesper Hastrup

AU - Aguinaga, Luis

AU - Arbelo, Elena

AU - Böhm, Michael

AU - Farhan, Hasan Ali

AU - Hobbs, F D Richard

AU - Martínez-Rubio, Antoni

AU - Militello, Claudio

AU - Naik, Nitish

AU - Noubiap, Jean Jacques

AU - Perel, Pablo

AU - Piñeiro, Daniel José

AU - Ribeiro, Antonio Luiz

AU - Stepinska, Janina

N1 - Copyright: © 2021 The Author(s).

PY - 2021/5/27

Y1 - 2021/5/27

N2 - The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death and disability. Atrial fibrillation (AF) is one of these conditions and is an increasing problem due to ageing of the world's population and an increase in cardiovascular risk factors that predispose to AF. The goal of the AF roadmap was to provide guidance on priority interventions that are feasible in multiple countries, and to identify roadblocks and potential strategies to overcome them. Since publication of the AF Roadmap in 2017, there have been many technological advances including devices and artificial intelligence for identification and prediction of unknown AF, better methods to achieve rhythm control, and widespread uptake of smartphones and apps that could facilitate new approaches to healthcare delivery and increasing community AF awareness. In addition, the World Health Organisation added the non-vitamin K antagonist oral anticoagulants (NOACs) to the Essential Medicines List, making it possible to increase advocacy for their widespread adoption as therapy to prevent stroke. These advances motivated the WHF to commission a 2020 AF Roadmap update. Three years after the original Roadmap publication, the identified barriers and solutions were judged still relevant, and progress has been slow. This 2020 Roadmap update reviews the significant changes since 2017 and identifies priority areas for achieving the goals of reducing death and disability related to AF, particularly targeted at low-middle income countries. These include advocacy to increase appreciation of the scope of the problem; plugging gaps in guideline management and prevention through physician education, increasing patient health literacy, and novel ways to increase access to integrated healthcare including mHealth and digital transformations; and greater emphasis on achieving practical solutions to national and regional entrenched barriers. Despite the advances reviewed in this update, the task will not be easy, but the health rewards of implementing solutions that are both innovative and practical will be great.

AB - The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death and disability. Atrial fibrillation (AF) is one of these conditions and is an increasing problem due to ageing of the world's population and an increase in cardiovascular risk factors that predispose to AF. The goal of the AF roadmap was to provide guidance on priority interventions that are feasible in multiple countries, and to identify roadblocks and potential strategies to overcome them. Since publication of the AF Roadmap in 2017, there have been many technological advances including devices and artificial intelligence for identification and prediction of unknown AF, better methods to achieve rhythm control, and widespread uptake of smartphones and apps that could facilitate new approaches to healthcare delivery and increasing community AF awareness. In addition, the World Health Organisation added the non-vitamin K antagonist oral anticoagulants (NOACs) to the Essential Medicines List, making it possible to increase advocacy for their widespread adoption as therapy to prevent stroke. These advances motivated the WHF to commission a 2020 AF Roadmap update. Three years after the original Roadmap publication, the identified barriers and solutions were judged still relevant, and progress has been slow. This 2020 Roadmap update reviews the significant changes since 2017 and identifies priority areas for achieving the goals of reducing death and disability related to AF, particularly targeted at low-middle income countries. These include advocacy to increase appreciation of the scope of the problem; plugging gaps in guideline management and prevention through physician education, increasing patient health literacy, and novel ways to increase access to integrated healthcare including mHealth and digital transformations; and greater emphasis on achieving practical solutions to national and regional entrenched barriers. Despite the advances reviewed in this update, the task will not be easy, but the health rewards of implementing solutions that are both innovative and practical will be great.

UR - http://www.scopus.com/inward/record.url?scp=85108100126&partnerID=8YFLogxK

U2 - 10.5334/GH.1023

DO - 10.5334/GH.1023

M3 - Review

C2 - 34211827

VL - 16

SP - 41

JO - Global Heart

JF - Global Heart

SN - 2211-8160

IS - 1

M1 - 41

ER -

ID: 68415011